Login / Signup

Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy.

Kewen HeNahum Puebla-OsorioHampartsoum B BarsoumianDuygu SezenZahid RafqThomas S RiadYun HuAiling HuangTifany A VossClaudia S Kettlun LeytonLily Jae SchudaEthan HsuJoshua HeiberMaria-Angelica CortezJames W Welsh
Published in: Journal of experimental & clinical cancer research : CR (2024)
Keyphrases
  • radiation therapy
  • dna damage
  • cell cycle
  • replacement therapy
  • radiation induced
  • locally advanced
  • squamous cell carcinoma
  • oxidative stress